Clinical Trial Update: Flavopiridol in Treating Patients With Metastatic Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating flavopiridol for metastatic malignant melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Flavopiridol (alvocidib)

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED